Background: Radiomics or computer-extracted texture features derived from MRI have been shown to help quantitatively characterize prostate cancer (PCa). Radiomics have not been explored depth in the context of predicting biochemical recurrence (BCR) of PCa. Purpose: To identify a set of radiomic features derived from pretreatment biparametric MRI (bpMRI) that may be predictive of PCa BCR. Study Type: Retrospective. Subjects: In all, 120 PCa patients from two institutions, I 1 and I 2 , partitioned into training set D 1 (N 5 70) from I 1 and independent validation set D 2 (N 5 50) from I 2 . All patients were followed for 3 years. Sequence: 3T, T 2 -weighted (T 2 WI) and apparent diffusion coefficient (ADC) maps derived from diffusion-weighted sequences. Assessment: PCa regions of interest (ROIs) on T 2 WI were annotated by two experienced radiologists. Radiomic features from bpMRI (T 2 WI and ADC maps) were extracted from the ROIs. A machine-learning classifier (C BCR ) was trained with the best discriminating set of radiomic features to predict BCR (p BCR ). Statistical Tests: Wilcoxon rank-sum tests with P < 0.05 were considered statistically significant. Differences in BCR-free survival at 3 years using p BCR was assessed using the Kaplan-Meier method and compared with Gleason Score (GS), PSA, and PIRADS-v2. Results: Distribution statistics of co-occurrence of local anisotropic gradient orientation (CoLlAGe) and Haralick features from T 2 WI and ADC were associated with BCR (P < 0.05) on D 1 . C BCR predictions resulted in a mean AUC 5 0.84 on D 1 and AUC 5 0.73 on D 2 . A significant difference in BCR-free survival between the predicted classes (BCR 1 and BCR-) was observed (P 5 0.02) on D 2 compared to those obtained from GS (P 5 0.8), PSA (P 5 0.93) and PIRADS-v2 (P 5 0.23). Data Conclusion: Radiomic features from pretreatment bpMRI can be predictive of PCa BCR after therapy and may help identify men who would benefit from adjuvant therapy.
these cases occur within the first 2 years. 4 Men with BCR have a higher risk of metastatic disease and death from PCa progression compared to those without BCR. 2 Therefore, predicting which men will develop BCR could allow for early identification of patients who might benefit from adjuvant therapy.
There is growing evidence supporting the use of multiparametric magnetic resonance imaging (mpMRI) before and after treatment in men with PCa (PCa detection, staging, and localization of sites of disease recurrence [5] [6] [7] [8] ). More recently, there has been interest in using information obtained from pretreatment mpMRI to predict the occurrence of BCR. [9] [10] [11] Radiomics refers to computer-based extraction of texture and image features from radiographic images. These features are used to characterize the underlying tumor microarchitecture and heterogeneity, which is subtle and not immediately visible on routine imaging. Radiomic features derived from mpMRI have been shown to be useful in PCa detection and localization. [12] [13] [14] [15] [16] In the context of BCR prediction using radiomic features, Gnep et al 17 found that
Haralick features obtained from T 2 -weighted images (T 2 WI) were significantly associated with BCR occurrence. However, this inference was drawn from a limited cohort of 74 men and the study also lacked validation on an independent test set.
In our study, we set out to assess additional classes of features including Gabor features 18 (which capture filter responses at multiple scales and orientations), Laws texture energy descriptors (which capture filter responses that represent edges, spottiness, waves, and ripple patterns), and cooccurrence of local anisotropic gradient orientations (CoLlAGe) features 19 in the context of predicting PCa BCR and test using an independent validation dataset. The goal of our study was to identify a comprehensive set of radiomic features of PCa derived from pretreatment bpMRI using a machine-learning classifier to predict the probability of PCa BCR occurrence.
Materials and Methods
This retrospective study consisted of patients from two institutions, I 1 and I 2 , which was compliant with the Health Insurance Portability and Accountability Act (HIPAA) and approved by the Institutional Review Board (IRB), either with a waiver of informed consent (I 1 ) or with written informed consent before enrollment (I 2 ).
Patient Selection
From I 1 , information from 1865 male patients with suspected or confirmed PCa who underwent 3T mpMRI of the prostate between 2009 and 2013 was acquired. Of these, 874 men underwent mpMRI before RP or RT. Patient records were reviewed and were included in the analysis if they 1) had documented BCR or 2) did not have BCR but followed for 3 years. BCR was defined as two consecutive readings of prostate-specific antigen (PSA) >0.2 ng/mL for men who underwent RP 20 and as an increase in PSA >2 ng/mL compared to the initial PSA nadir value for men who underwent RT (with or without hormonal therapy). 21 Of the 113 cases identified through this process, 43 were excluded ( Fig. 1 (Table 1) . At I 2 , a total of 52 patients underwent mpMRI scan prior to RP between 2010 and 2013. The patients were followed for 3 years and time to recurrence was noted. Of these 52, two patients were excluded since no suspicious PCa lesions were identified by a radiologist, resulting in 50 PCa patients (7 BCR 1 and 43 BCR-) which were used as an independent validation cohort D 2 to robustly validate the findings across institutions (Table 1) .
MRI Protocol and Annotations
All mpMRI examinations of D 1 were performed using a 3T MR scanner with either a surface pelvic phase array coil (PPAC) or an endorectal coil (ERC). The pulse sequences analyzed in the current study included axial turbo spin-echo (TSE) T 2 WI, axial diffusionweighted imaging (DWI) with creation of an apparent diffusion coefficient (ADC) map using vendor-specific software. Patients in D 2 underwent mpMRI examination performed using a 3T MR scanner and a PPAC. 22, 23 The pulse sequences analyzed in the study included TSE T 2 WI, axial DWI with the creation of an ADC map. Detailed MRI acquisition parameters are provided in Table  2 . Additional sequences, such as dynamic contract-enhanced MRI, proton MR spectroscopy, and various other sequences were acquired but not analyzed in the current study.
A board-certified radiologist with fellowship training in abdominal imaging and 7 years of experience in prostate imaging reviewed the mpMRI datasets and delineated contours of the dominant PCa lesions in D 1 (using 3D Slicer 24 ) using the histopathology template reports from RPs and biopsies as a reference, while another radiologist with 8 years of experience in prostate imaging similarly reviewed the cases in D 2 . Prostate Imaging-Reporting and Data system version 2 (PIRADS-v2) scores were assigned to the annotated lesions. 25 The whole prostate gland and dominant PCa lesions were delineated on axial T 2 WI datasets. DWI datasets were coregistered with T 2 WI using rigid deformation. 26 After treatment, all patients underwent periodic follow-up according to the established clinical protocol (3-6 months in the first year and 6-12 months the following years), which included serial measurements of PSA levels, recording of recurrence dates for BCR1 cases, and date of last follow-up for BCR-cases. BCRcases were censored at their last follow-up date for survival analysis. One patient from D 1 died <36 months after RP and five patients from D 2 at 4, 9, 23, 26, and 28 months after RP due to nonPCa-related causes without evidence of BCR.
MRI Preprocessing
T 2 WI obtained with an ERC are often affected by bias field artifacts, which were corrected using a method described previously. 27 With this method, the bias field is first estimated from acquired image data and is later subtracted from the acquired scan. Additionally, intensity drift artifacts arising from intrapatient variability in MRI can cause image intensities to lack in tissue-specific meaning. This was corrected using an intensity standardization method described previously 28 which normalizes the intensity histograms (within the delineated prostate) to a similar range providing tissuespecific meaning to the intensities. The images were scaled in a piecewise manner using histogram landmarks at every 10 th percentile. These landmarks are automatically computed from the data. We computed the standardization map (piecewise linear function) for just the prostate volume. All the prostates were standardized to a single template. This is illustrated in Fig. 2 where the histograms of image intensities within the prostates of different patients are shown before and after standardization. The above preprocessing steps were aimed to minimize the differences related to the coil utilized (ERC or SC).
Radiomic Feature Extraction
Radiomic features employed in this study were extracted on a pervoxel basis from T 2 WI and ADC maps within the annotated cancerous regions. The choice of radiomic features for characterizing PCa lesions was motivated by their use in previous studies. 12, 15, 18, 19, 29 We also included additional features that have recently been shown to be capable of distinguishing among subtly different disease types on imaging 19 (Table 3) . Intensity-based tumor heterogeneity was characterized using Haralick, Gabor, and Laws features; gradient-based tumor heterogeneity was characterized using CoLlAGe and gradient features. A total of 150 (75 each from T 2 WI and ADC maps) radiomic features were extracted on a per-voxel basis from pretreatment T 2 WI and ADC maps (Fig. 3) . Mean, variance, skewness, and kurtosis were computed over the feature vectors within each lesion. Therefore, a total of 150 3 4 5 600 features were computed for each lesion.
Training a Machine-Learning Classifier
The training dataset D 1 was used to extract 75 radiomic features. Distribution statistics (including mean, variance, skewness, and kurtosis) of these features were computed for each region of interest (ROI), including all slices. Feature selection methods were employed to provide an optimal discriminating set of features. 30, 31 Minimum redundancy maximum relevance (mRMR), joint mutual information (JMI), and conditional mutual information method (CMIM) were the three feature selection methods chosen for this study, as these approaches have been previously employed in radiomic studies involving PCa localization. 15, 32, 33 The most discriminating features were then used to train a machine-learning classifier in conjunction with class labels (BCR 1 or BCR-). Linear discriminant analysis (LDA), support vector machines (SVM), and decision trees or random forests (RF) are widely used machinelearning-based classification methods that have been employed by previous studies in the context of radiomic features-based classification. 13, 15, 34 Each of these classification methods (LDA, SVM, and RF) was used in conjunction with the three feature selection methods to train a total of nine different prediction models. Given a radiomic feature vector from a test case, the prediction models yield a probability score (p BCR ) that the feature vector belongs to either the BCR1 or BCR-class. A 3-fold crossvalidation scheme with 150 runs for each of the nine prediction models was performed, and a receiver operating characteristic (ROC) curve was generated by varying the threshold on the probability scores obtained from the classifier. The classifier that yielded a high area under the ROC curve (AUC) and a small standard deviation over the learning set was identified as the , and PIRADS-v2) and radiomic features was also used to train a machine-learning classifier and assess the performance. 
Statistical Analysis
To anticipate a 70% incidence of BCR in the positive class and allowing for false detection in 30% of patients in the negative class (with an enrollment ratio of 1 between the classes), 46 patient studies were needed to obtain a power of 80% and a (type 1 error) 5 0.05. A total of N 5 70 patient studies were employed for classifier training. A univariate Cox proportional hazards analysis was performed using the R software environment. This analysis was performed on D 1 to determine individual radiomic features predictive of BCR. Hazard ratios (HRs) and the confidence interval (CI) of each feature associated with BCR were computed. Harrell's Cindex was also estimated to evaluate the correlation of each feature to BCR and to rank features in order of C-indices. P < 0.05 was used to assess statistical significance.
The predicted class probability p BCR obtained from C BCR on D 2 was converted to a class label (BCR 1 or BCR-) using a threshold of 0.5. Individual machine-learning classifiers were trained using PSA, pretreatment biopsy GS, and PIRADS-v2 to predict class labels for comparison with p BCR . The class labels were then used to analyze the difference in survival using Kaplan-Meier analysis. A log-rank test was performed to assess statistical significance (P < 0.05).
Results

Predicting BCR Using a Machine-Learning Classifier Trained With Radiomic Features
The top-discriminating 10 radiomic features that showed significant differences (P < 0.05) between BCR1 and BCRlesions ranked according to C-index are listed in Table 4 . A complete list of significant radiomic features is provided as Supplementary Material.
On D 1 , the SVM classifier was found to perform better than the LDA and RF classifiers in terms of AUC (Fig. 4) . The SVM classifier with the JMI feature selection scheme was chosen as the best predictive model (C BCR ) and used for validation on D 2 . This model resulted in an AUC 5 0.84 on D 1 and AUC 5 0.73 on D 2 (Fig. 5) . The skewness and kurtosis statistics of the CoLlAGe feature from ADC maps and Haralick features from T 2 WI were significantly associated with BCR (P < 0.05) on D 1 ( Table 4) Survival Analysis A significant separation in Kaplan-Meier survival curves between the 2 classes of patients (P 5 0.02) was observed using p BCR on D 2 . In comparison, none of the clinical variables including GS (P 5 0.81), PSA (P 5 0.93), and PI-RADS-v2 (P 5 0.23) resulted in a statistically significant separation (Fig. 6 ). It may be noted that D 2 is imbalanced and may not be sufficient to establish significant conclusions.
Effect of Combining Clinical Parameters and Radiomics in Predicting BCR
Combining clinical variables with radiomics radiomic features improved prediction of BCR on training set D 1 (AUC 5 0.91) compared to radiomics alone (AUC 5 0.84). However, a marginal improvement in performance (AUC 5 0.74) was observed on the validation set D 2 over just the radiomic features (AUC 5 0.73). Our combination strategy involved integrating clinical variables with the best discriminating set of radiomic features. The results in terms of AUC on the training and validation set along with different combinations rank ordered in terms of performance on the validation set are presented in Table 5 .
Effect of Treatment Type on Radiomic Features for BCR Prediction
Only patients who underwent surgery in the training set were used to train a different radiomic classifier. We obtained an Table 6 .
Discussion
In this study we identified a comprehensive set of radiomic features of PCa derived from T 2 WI and ADC maps that correlated with BCR. Additionally, using a machine-learning classifier, we showed that these features could be used to predict BCR.
Gnep et al 17 previously demonstrated that Haralick features derived from T 2 WI are associated with BCR occurrence, suggesting that radiomic analysis may be capable of capturing the differences in BCR1 and BCR-lesions on pretreatment mpMRI. In our study, a more comprehensive set of radiomic features were analyzed and distribution statistics, specifically skewness and kurtosis, of T 2 WI-derived Haralick features and ADC-derived CoLlAGe entropy were found to be strongly predictive of BCR in men with PCa.
Additionally, these results were tested on an independent validation dataset acquired from a different institution. CoLlAGe features quantify local intensity gradient patterns in images and capture gradient-based tumor FIGURE 6: Kaplan-Meier survival curves using predicted BCR1 (red) and BCR-(blue) classes by machine-learning classifiers trained using radiomic features (C BCR ), GS, PSA and PIRADS-v2. Statistically significant separation in BCR free survival between the predicted BCR1 and BCR-patients is observed with C BCR (P 5 0.02) as opposed to GS (P 5 0.81), PSA (P 5 0.93), and PIRADS-v2 (P 5 0.23). Statistical significance (P < 0.05) was established using the log-rank test. heterogeneity. The distribution of these gradients is captured by various statistics such as entropy, inertia, and energy, which were found to be different in BCR1 and BCRlesions. There was a predominantly higher disorder of gradients in BCR1 lesions compared to BCR-lesions, and distributions of these features within the lesion were found to capture the differences between the two categories. Similar to CoLlAGe features, we observed that distribution statistics of Haralick features derived from T 2 WI, captured by skewness and kurtosis metrics, were statistically significantly different between BCR1 and BCR-lesions. Haralick features are a result of various statistics computed over a matrix of spatial voxel-intensity relationships. An overexpression of Haralick features typically indicates more intensity-based tumor heterogeneity, which is observed in recurrent lesions. The distribution statistics quantified by skewness and kurtosis again demonstrated significant differences between BCR1 and BCR-lesions.
The set of top discriminating radiomic features demonstrated a high predictive accuracy on both D 1 and D 2 . The result on D 2 is particularly interesting, given that these patients are from a different institution than what the radiomic classifier was trained on.
The study by Gnep et al 17 demonstrated that T 2 WIderived Haralick features were associated with BCR. These features were extracted from the training dataset, and the same machine-learning classification method (RF) was used to train a classification model. When the classifier was tested on D 2 , the resultant AUC was considerably lower than we found. Although our results indicated that Haralick features are associated with BCR, the additional features we assessed, including CoLlAGe and Gabor features, carry important complementary information that improved predictive accuracy. The top-ranked radiomic features also yielded a high C-index (0.7 for the top radiomic features), showing a high correlation with BCR. This was also reflected in the Kaplan-Meier analysis, which showed significant differences in survival between BCR1 and BCR-patients predicted by the classifier on D 2 . On the other hand, none of the clinical parameters including GS, PSA, and PIRADS-v2 were able to show significant differences in D 2 . This indicates that clinical variables suggesting aggressive disease may not always be predictive of BCR and radiomic features capturing subtle imaging signatures may add complementary and additional value in predicting BCR for these patients. However, D 2 is imbalanced and additional experiments with a larger and balanced cohort are necessary to conclusively establish these findings.
We observe that combining clinical variables with radiomics almost always resulted in better performance on the training set. However, the AUC was not consistently high in the validation set. The clinical variables of patients used in the training set were already predictive of BCR, since the patients were carefully curated. And a combination of clinical variables with radiomics improved BCR prediction. With the validation set, the clinical variables were not strongly predictive of BCR by themselves. A combination of radiomics and clinical variables marginally improved the AUC in the validation set. None of the other combinations improved the AUC beyond radiomics alone.
Our study consisted of images from different scanners and coils that affect images in terms of resolution and intensity bias. Radiomic features from higher-resolution images may capture finer texture and be more descriptive of underlying heterogeneity. While correcting ERC-related bias-field artifacts would not render it completely equivalent to PPAC, intensity standardization helps alleviate these issues to a large extent.
While a majority of patients in D 1 and D 2 underwent RP, there were a few patients who underwent RT/hormonal therapy. Training a machine-learning classifier using radiomic features obtained from patients who underwent RP alone resulted in a good classification performance on D 2 , as indicated by the AUCs. Also, the top discriminating features remained consistent. This suggests that controlling for treatment (surgery) did not significantly affect our results and conclusions. In other words, the radiomic features appeared to be picking up patterns of disease recurrence that transcended the treatment modality. For instance, it is worth noting that the same types of features were identified as predictive of BCR when controlling for treatment modality. However, we need additional patient data who were treated with radiotherapy, hormone therapy to draw strong conclusions about the effect of treatment modality on radiomic features for predicting BCR.
Our study has some limitations to be acknowledged. 1) The delineation of cancer lesions on T 2 WI and ADC was performed by a single radiologist at I 1 and I 2 . Ideally, the correlation should be performed with slides from RP specimens.
2) The number (n 5 7) of BCR 1 patients in D 2 were very small in comparison with BCR-patients (n 5 43). However, we still obtained a reasonable AUC on D 2 , suggesting the robustness of radiomic features across institutions in predicting BCR, given that AUC is a strong indicator of classification performance in skewed datasets. 3) Patients in D 2 were all scanned with a surface coil, while the majority of the patients in D 1 were scanned with an endorectal coil. While this is not optimal, the effect of scanners and coils on the images was somewhat mitigated through bias-field and intensity standardization methods. 4) The two classes of patients (BCR1 and BCR-) had variable follow-up times. BCR may thus have not been the appropriate endpoint and predicting time to recurrence may have been more appropriate. However, this would require a large number of patients spanning a range of recurrence times to train a regression model. This is an interesting avenue for future research. 5) ADC maps were acquired using different b-values between the institutions. While this did not significantly affect our top discriminating features, since they are based on relative statistics, as part of future work we plan to acquire data from multiple institutions with ADC maps acquired using identical DWI acquisition and postprocessing parameters.
In conclusion, radiomic features derived from pretreatment bpMRI (T 2 WI and ADC maps) were predictive of prostate cancer BCR. These observations held on an independent validation set that was acquired from a different institution. The ability to identify men at elevated risk for BCR, before treatment, may potentially allow for the patients to benefit from alternative and/or aggressive treatment options including adjuvant therapy.
